PROSHARES TR - SHRT HGH YIELD (SJB)

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / SHRT HGH YIELD
Total 13F shares
8,052,347
Share change
+1,237,327
Total reported value
$152,999,078
Put/Call ratio
4.1%
Price per share
$19.00
Number of holders
62
Value change
+$22,665,531
Number of buys
38
Number of sells
28

Institutional Holders of PROSHARES TR - SHRT HGH YIELD (SJB) as of Q4 2022

As of 31 Dec 2022, PROSHARES TR - SHRT HGH YIELD (SJB) was held by 62 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,052,347 shares. The largest 10 holders included HighTower Advisors, LLC, Csenge Advisory Group, Hilltop Holdings Inc., REUTER JAMES WEALTH MANAGEMENT, LLC, Thomas J. Herzfeld Advisors, Inc., VISTA FINANCE, LLC, LPL Financial LLC, Park Edge Advisors, LLC, Empowered Funds, LLC, and JANE STREET GROUP, LLC. This page lists 62 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.